Clinical Trial Update: Carfilzomib for the Prevention of Graft Versus Host Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating carfilzomib for prevention of graft-versus-host disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Sheba Medical Center | Conditions: Graft-versus-host Disease | Phase 1 | Status: UNKNOWN